Chemotherapy-Free Triplet 'Sets a New Benchmark' in Follicular Lymphoma

(MedPage Today) — ORLANDO — Adding the bispecific antibody epcoritamab (Epkinly) to a standard chemotherapy-free regimen for relapsed or refractory follicular lymphoma improved responses and reduced the risk of disease progression or death…

Source link : https://www.medpagetoday.com/meetingcoverage/ashhematology/118878

Author :

Publish date : 2025-12-07 21:18:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

Chemotherapy-Free Triplet ‘Sets a New Benchmark’ in Follicular Lymphoma

‘This Would Be a Hugely Important Finding’: What We Heard This Week

Sickle Cell Pain Management in the ED Remains Suboptimal

Related Posts

Cancer Screening Gaps Leave People With HIV at Elevated Risk

AMA Calls for Government-Enforced Digital Interoperability

‘Weight-loss jab helped me find my cancer’

Why are fewer people donating their organs?

Self-Acupressure May Ease Fatigue in Ovarian Cancer

Fenofibrate: Effective in Children With High Triglycerides?

Cancer Screening Gaps Leave People With HIV at Elevated Risk

AMA Calls for Government-Enforced Digital Interoperability

Why are fewer people donating their organs?

‘Weight-loss jab helped me find my cancer’

Self-Acupressure May Ease Fatigue in Ovarian Cancer

Fenofibrate: Effective in Children With High Triglycerides?

Seafarers were visiting remote Arctic islands over 4000 years ago

‘It’s Not Normal but It’s Not Really Abnormal’: What We Heard This Week

Categories

Archives